# RTOG 0933 (NCT01227954)

> Avoiding the Hippocampus During Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

No report yet. It can be ordered.

- Drugs tested: none (the trial tests a strategy, not a drug)
- Indication: brain metastases

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01227954
- Phase: PHASE2
- Status: COMPLETED
- Sponsor: Radiation Therapy Oncology Group
- Conditions: Cognitive/Functional Effects; Metastatic Cancer; Unspecified Adult Solid Tumor, Protocol Specific
- Interventions: intensity-modulated radiation therapy
- Enrollment: 113
- Primary outcome: Percent Change in Delayed Recall at 4 Months as Measured by the Hopkins Verbal Learning Test-Revised (HVLT-R)

## Indexed commentary on RTOG 0933 so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 4 posts on X
- 1 YouTube video

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=rtog-0933-nct01227954